Pricing

Dystrogen Therapeutics

0 followers

‌

Dystrogen Therapeutics is a clinical-stage regenerative medicine company focusing on rare diseases. The company is currently testing DEC therapy for Duchenne Muscular Dystrophy.

Industries

Biotechnology

Headquarters

Chicago, United States

Employees

1-10

Links

Org chart

Kris Siemionow

Co-Founder & CEO

Collapse

Maria Siemionow

Founder & CSO

Board & advisors

Paul Lewicki

Co-Founder & Board Member

Teams

Leadership Team

3 people · 0 jobs

Offices

HQ
0 people · 0 jobs

Gilead Sciences

179 followers

Regeneron

148 followers

Illumina

82 followers

Agilent Technologies

90 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

50 followers

GRAIL

32 followers

Cytiva

20 followers

PerkinElmer

13 followers

Editas Medicine

5 followers

Organogenesis